Document:

Amendment No. 1 to Rights Agreement by Computershare Trust Company, NA

 Exhibit 4.1 
 AMENDMENT NO. 1 TO RIGHTS AGREEMENT 
 THIS AMENDMENT
NO. 1 TO RIGHTS AGREEMENT (the Amendment) is made as of the 4th day of June, 2008, by and between TERCICA, INC., a
Delaware corporation (the Company), and COMPUTERSHARE TRUST COMPANY, N.A. (the Rights Agent). 
 WHEREAS, the Company is entering into an Agreement and Plan of Merger (as the same may be amended from time to time, the
Merger Agreement), among the Company, Beaufour Ipsen Pharma, a société par actions simplifiée organized under the laws of France (Purchaser), Tribeca Acquisition Corporation, a corporation
organized under the laws of the State of Delaware and a wholly-owned subsidiary of Purchaser (Merger Sub), pursuant to which Merger Sub will merge with and into the Company upon the terms and subject to the conditions set forth in the
Merger Agreement (such merger is referred to in this Amendment as the Merger); 
 WHEREAS, concurrently
with the execution and delivery of the Merger Agreement, certain securityholders of the Company (such parties, the Voting Parties) are each entering into a voting and support agreement (each a Stockholder Support Agreement
and together the Stockholder Support Agreements) with Purchaser and Merger Sub pursuant to which, among other things, each of the Voting Parties will agree, subject to certain conditions, to vote its shares of the common stock,
par value $0.001 per share, of the Company in favor of adoption of the Merger Agreement and approval of the Merger; 
 WHEREAS, the Company and the Rights Agent are parties to that certain Rights Agreement, dated as of October 13, 2006 (the Rights Agreement); 
 WHEREAS, the Company desires to amend the Rights Agreement in connection with the execution and delivery of the Merger Agreement
and each Stockholder Support Agreement and the consummation of the Merger and the other transactions contemplated thereby; 
 WHEREAS, in accordance with Section 27 of the Rights Agreement, the Board of Directors of the Company has approved this Amendment and authorized its appropriate officers to execute and deliver the same to the
Rights Agent; and 
 WHEREAS, in accordance with Section 27 of the Rights Agreement, Ipsen, S.A., a French
société anonyme, has approved this Amendment. 
 NOW, THEREFORE, in accordance with
the procedures for amendment of the Rights Agreement set forth in Section 27 thereof, and in consideration of the foregoing and the mutual agreements herein set forth, the parties hereby agree as follows: 
 1.    Capitalized terms that are not otherwise defined herein shall have the meanings ascribed to them in the Rights
Agreement. 
 2.    The definition of “Acquiring Person” set forth in Section 1(a) of the Rights
Agreement is hereby amended by adding the following sentence to the end of said Section 1(a): 
 “Notwithstanding anything in this
Agreement to the contrary, no Merger Party (or any of such Merger Party’s Affiliates or Associates) shall be or become an “Acquiring Person” by reason of, and the term “Acquiring Person” shall not include any Merger Party
(or any of such Merger Party’s Affiliates or Associates) by reason of, (i) the approval, execution and/or delivery of the Agreement and Plan of Merger, dated as of June 4, 2008, among the Company, Beaufour Ipsen Pharma, a
société par actions simplifiée organized under 

  

 1. 

 
the laws of France (“Purchaser”), Tribeca Acquisition Corporation, a corporation organized under the laws of the State of Delaware and a
wholly-owned subsidiary of Purchaser (“Merger Sub” and, together with Purchaser, the “Purchaser Parties”) (such Agreement and Plan of Merger, as the same may be amended from time to time, is referred to in this
Agreement as the “Merger Agreement”) or the approval, execution and/or delivery of any amendment thereto, (ii) the approval, execution and/or delivery of any of the Voting Agreements, each dated as of June 4, 2008 (such
Voting Agreements, as the same may be amended from time to time, are collectively referred to in this Agreement as the “Stockholder Support Agreements”), among Purchaser, Merger Sub and the securityholders of the Company that are
parties thereto (such securityholders of the Company, in their capacity as parties to the Stockholder Support Agreements, are collectively referred to in this Agreement as the “Voting Parties” and, together with the Purchaser
Parties, the “Merger Parties”) or the approval, execution and/or delivery of any amendment to any of such Stockholder Support Agreements, (iii) the approval, execution and/or delivery of any other contract or instrument in each
case entered into by the Company in connection with the Merger Agreement or the Stockholder Support Agreements or the approval, execution and/or delivery of any amendment thereto, (iv) the merger of Merger Sub with and into the Company pursuant
to, and on the terms and subject to the conditions set forth in, the Merger Agreement (such merger is referred to in this Agreement as the “Merger”), (v) the consummation of the Merger or any other transactions contemplated by
the Merger Agreement, the Stockholder Support Agreements or the contracts or other instruments referred to in clause (iii) above (the Merger Agreement, the Stockholder Support Agreements and such other contracts and instruments are collectively
referred to in this Agreement as the “Merger Transaction Agreements”), or (vi) the announcement of any of the Merger Transaction Agreements, the Merger or any other transactions contemplated by the Merger Transaction
Agreements, or the announcement of any consummation thereof.” 
 3.    The definition of “Beneficial
Owner” set forth in Section 1(d) of the Rights Agreement is hereby amended by adding the following sentence to the end of said Section 1(d): 
 “Notwithstanding anything in this Agreement to the contrary, no party to any of the Merger Transaction Agreements shall be deemed to be the Beneficial Owner of any Common Shares held by any other party to any
such Merger Transaction Agreement solely by virtue of the execution and delivery of any such Merger Transaction Agreement or any amendment thereof or the performance of such party’s rights and obligations under any such Merger Transaction
Agreement or any such amendment.” 
 4.    The definition of “Interested Stockholder” set forth in
Section 1(m) of the Rights Agreement is hereby amended by adding the following sentence to the end of said Section 1(m): 
 “Notwithstanding anything in this Agreement to the contrary, no Merger Party (or any of such Merger Party’s Affiliates or Associates) shall be or become an “Interested Stockholder” by reason of, and the term
“Interested Stockholder” shall not include any Merger Party (or any of such Merger Party’s Affiliates or Associates) by reason of, (i) the approval, execution and/or delivery of any of the Merger Transaction Agreements or any
amendment thereto, (ii) the Merger, (iii) the consummation of the Merger or any other transactions contemplated by any of the Merger Transaction Agreements, or (iv) the announcement of any of the Merger Transaction Agreements, the
Merger or any other transactions contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof.” 
  

 2. 

 5.    The definition of “Shares Acquisition Date” in Section l(w) of
the Rights Agreement is hereby amended by adding the following sentence to the end of said Section l(w): 
 “Further, notwithstanding
anything in this Agreement to the contrary, no Shares Acquisition Date shall be deemed to have occurred by reason of (i) the approval, execution and/or delivery of any of the Merger Transaction Agreements or any amendment thereto, (ii) the
Merger, (iii) the consummation of the Merger or any other transactions contemplated by any of the Merger Transaction Agreements, or (iv) the announcement of any of the Merger Transaction Agreements, the Merger or any other transactions
contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof.” 
 6.    The definition of “Transaction” in Section l(y) of the Rights Agreement is hereby amended by adding the following sentence to the end of said Section l(y): 
 “Notwithstanding anything in this Agreement to the contrary, no Transaction shall be deemed to have occurred by reason of (i) the approval,
execution and/or delivery of any of the Merger Transaction Agreements or any amendment thereto, (ii) the Merger, (iii) the consummation of the Merger or any other transactions contemplated by any of the Merger Transaction Agreements, or
(iv) the announcement of any of the Merger Transaction Agreements, the Merger or any other transactions contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof.” 
 7.    Section 1 (Certain Definitions) is hereby amended by adding the following clause (dd) to the end of said
Section 1: 
 “(dd) Each of the following terms shall have the meaning set forth in the definition of “Acquiring Person”
in Section 1(a) hereof: “Purchaser”, “Merger Sub”, “Purchaser Party”, “Voting Party”, “Merger Party”, “Merger Agreement”, “Stockholder
Support Agreement”, “Merger” and “Merger Transaction Agreements”.” 
 8.    Section 3(a) of the Rights Agreement is hereby amended by adding the following sentence to the end of said Section 3(a): 
 “Further, notwithstanding anything in this Agreement to the contrary, no Distribution Date shall be deemed to have occurred by reason of (i) the
approval, execution and/or delivery of any of the Merger Transaction Agreements or any amendment thereto, (ii) the Merger, (iii) the consummation of the Merger or any other transactions contemplated by any of the Merger Transaction
Agreements, or (iv) the announcement of any of the Merger Transaction Agreements, the Merger or any other transactions contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof.” 
 9.    Section 7(a) of the Rights Agreement is hereby amended and restated to read in its entirety as follows: 

“(a)    The registered holder of any Right Certificate may exercise the Rights evidenced thereby (except as otherwise
provided herein) in whole or in part at any time after the Distribution Date upon surrender of the Right Certificate, with the form of election to purchase on the reverse side thereof duly executed, to the Rights Agent at the office of the Rights
Agent designated for such purpose, together with payment of the Purchase Price for each one one-hundredth of a Preferred Share (or such other number of shares or 

  

 3. 

 
other securities) as to which the Rights are exercised, at or prior to the earliest of (i) the Close of Business on October 26, 2016, (ii) the
time at which the Rights are redeemed as provided in Section 23 hereof (the “Redemption Date”), (iii) the time at which such Rights are exchanged as provided in Section 24 hereof or (iv) the moment in time
immediately prior to the Effective Time (as such term is defined in the Merger Agreement) (the earlier to occur of the events described in clauses (i) and (iv) of this paragraph (a) shall be referred to herein as the “Final
Expiration Date”). Further, notwithstanding anything in this Agreement to the contrary, none of (i) the approval, execution and/or delivery of any of the Merger Transaction Agreements or any amendment thereto, (ii) the Merger,
(iii) the consummation of the Merger or any other transactions contemplated by any of the Merger Transaction Agreements, or (iv) the announcement of any of the Merger Transaction Agreements, the Merger or any other transactions
contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof, shall be deemed an event that causes the Rights to become exercisable under the provisions of this Section 7 or otherwise.” 
 10.    Section 11(a)(ii) of the Rights Agreement is hereby amended by adding the following sentence to the end of
said
 Section 11(a)(ii): 
 “Notwithstanding anything in this Agreement to the contrary, no event requiring an adjustment under
this Section 11(a) shall be deemed to have occurred by reason of (i) the approval, execution and/or delivery of any of the Merger Transaction Agreements or any amendment thereto, (ii) the Merger, (iii) the consummation of the
Merger or any other transactions contemplated by any of the Merger Transaction Agreements, or (iv) the announcement of any of the Merger Transaction Agreements, the Merger or any other transactions contemplated by the Merger Transaction
Agreements, or the announcement of any consummation thereof.” 
 11.    Section 13(a) of the Rights
Agreement is hereby amended by adding the following sentence to the end of said
 Section 13(a): 
 “Notwithstanding anything in
this Agreement to the contrary, none of the events described in clauses (x) through (z) of the first sentence of Section 13(a) shall be deemed to have occurred as a result of, nor shall an event have otherwise been deemed to have
occurred to cause an adjustment in accordance with this Section 13 (or otherwise) or to cause the Rights to become exercisable under this Agreement as a result of, (i) the approval, execution and/or delivery of any of the Merger
Transaction Agreements or any amendment thereto, (ii) the Merger, (iii) the consummation of the Merger or any other transactions contemplated by any of the Merger Transaction Agreements, or (iv) the announcement of any of the Merger
Transaction Agreements, the Merger or any other transactions contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof.” 
 12.    Section 30 of the Rights Agreement is hereby amended by adding the following sentence to the end of said Section 30: 
 “Further, nothing in this Agreement shall be construed to give any holder of Rights or any other Person any legal or equitable rights, remedies or
claims under this Agreement by virtue of (i) the approval, execution and/or delivery of any of the Merger Transaction Agreements or any amendment thereto, (ii) the Merger, (iii) the consummation of the Merger or any other transactions
contemplated by any of the Merger Transaction Agreements, or (iv) the announcement of any of the Merger Transaction Agreements, the 

  

 4. 

 
Merger or any other transactions contemplated by the Merger Transaction Agreements, or the announcement of any consummation thereof.” 
 13.    The Rights Agreement, as amended by this Amendment, shall remain in full force and effect in accordance with its terms.
In the event of any conflict, inconsistency or incongruity between any provision of this Amendment and any provision of the Rights Agreement, the provisions of this Amendment shall govern and control for purposes of the subject matter of this
Amendment only. This Amendment shall be construed in accordance with and as a part of the Rights Agreement, and all terms, conditions, representations, warranties, covenants and agreements set forth in the Rights Agreement and each other instrument
or agreement referred to therein, except as herein amended, are hereby ratified and confirmed. 
 14.    All of
the covenants and provisions of this Amendment by or for the benefit of the Company or the Rights Agent shall bind and inure to the benefit of their respective successors and assigns hereunder. 
 15.    Nothing in this Amendment shall be construed to give to any person or corporation other than the Company, a Purchaser
Party, the Rights Agent and the registered holders of the Right Certificates (and, prior to the Distribution Date, the Common Shares) any legal or equitable right, remedy or claim under this Amendment; but this Amendment shall be for the sole and
exclusive benefit of the Company, Purchaser, Merger Sub, the Rights Agent and the registered holders of the Right Certificates (and, prior to the Distribution Date, the Common Shares). 
 16.    If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other
authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or invalidated. 
 17.    This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall
be governed by and construed in accordance with the laws of such State applicable to contracts to be made and performed entirely within such State. 
 18.    This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and
the same instrument. 
 19.    The Company hereby certifies to the Rights Agent that this Amendment is in
compliance with Section 27 of the Rights Agreement (and covenants and agrees that from the date hereof, upon request by the Rights Agent, it shall deliver to the Rights Agent any further certificate as shall be reasonably required by the Rights
Agent to evidence such compliance). 
 20.    This Amendment shall be deemed effective as of the date first
written above (and on such date, immediately prior to the execution and delivery of the Merger Agreement and the other Merger Transaction Agreements), as if executed on such date. 
  

 5. 

 IN WITNESS WHEREOF, the parties herein have caused
this Amendment to be duly executed and attested, all as of the day and year first above written. 
  

					
	 ATTEST:
	 		 	TERCICA, INC.
			
	 /s/ Stephen N. Rosenfield
 Stephen N. Rosenfield
 Executive Vice President of Legal Affairs, General
 Counsel and Secretary
	 		 	 /s/ John A. Scarlett, M.D.
 John A. Scarlett, M.D.
 Chief Executive Officer

			
	 ATTEST:
	 		 	COMPUTERSHARE TRUST COMPANY, N.A.

									
					
	By:	 	 /s/
	 		 	By:	 	 /s/

	 Title: Relationship Manager
	 		 	Title: Manager

  

 6.Forbearance No.2, Limited Waiver and Modification to Loan and Security Agreement

 EXHIBIT 10.1 
 FORBEARANCE NO. 2, LIMITED WAIVER AND MODIFICATION 
 TO 
 LOAN AND SECURITY AGREEMENT 
 THIS FORBEARANCE NO. 2, LIMITED WAIVER AND MODIFICATION TO LOAN AND
SECURITY AGREEMENT (this “Forbearance”) is entered into this          day of May, 2008, by and among Bioject Medical Technologies, Inc., an
Oregon corporation and Bioject, Inc., each with its principal place of business at 20245 S.W. 95th Ave., Tualatin, OR 97062 USA (individually and collectively, “Borrower”) and PARTNERS FOR GROWTH, L.P. (“PFG”). Capitalized terms
used herein without definition shall have the same meanings given them in the Loan Agreement (as defined below). 
 RECITALS

 A. Borrower and PFG have entered into that certain Loan and Security Agreement dated as of August 31, 2007 (as may be
amended, restated, or otherwise modified, the “2007 Loan Agreement”) pursuant to which PFG has extended and conditionally-agreed to make available to Borrower certain advances of money and under which there is outstanding
$166,666.64 in principal and $574.04 in accrued and unpaid interest and $916.67 in accrued and unpaid collateral handling fee as of May 31, 2008. 
 B. In addition to the 2007 Loan Agreement, Borrower and PFG are party to a Term Loan and Security Agreement dated as of March 29, 2006 (the “Convertible Loan”), under which there is
outstanding $1,250,000 in principal and $5,381.94 in accrued and unpaid interest as of May 31, 2008, a Loan and Security Agreement dated as of December 11, 2006 (the “Revolving Loan Agreement”), under which there is
outstanding $108,030.54 in principal and $348.19 in accrued and unpaid interest and $594.17 in accrued and unpaid collateral handling fee as of May 31, 2008, and associated cross-corporate guarantees and security agreements (the
“Additional PFG Loans” and, together with the 2007 Loan Agreement, the “Outstanding PFG Loans”, and together with such documents, instruments and security agreements as were
executed reasonably contemporaneously with or in connection with the Outstanding PDF Loans, the “Loan Documents”). 
 C. Borrower and PFG entered into that certain Forbearance No. 1, Limited Waiver and Modification to Loan and Security Agreement dated as of November 19, 2007, as amended by that certain Amendment Forbearance No. 1,
Limited Waiver and Modification to Loan and Security Agreement is entered into as of December 19, 2007 (collectively, the “Initial Forbearance”). 
 D. But for the Forbearance, Borrower would be in default of the financial covenants set forth in the Loan Documents (the
“Default”). 
 E. The Forbearance Period under the Initial Forbearance ends June 1, 2008 and Borrower
(a) acknowledges the Default, (b) desires that PFG not declare an Event of Default or exercise other remedies under the Loan Documents due to the above-referenced Default (to “Forbear”) from the date hereof
until the earlier to occur of the termination of this Forbearance or September 15, 2008 (the “Extended Forbearance Period”), and (c) desires that PFG provide the conditional limited waiver of the Default upon the
terms and conditions more fully set forth herein. 
  

 1 

 F. Subject to the representations and warranties of Borrower herein and upon the terms and
conditions set forth in this Forbearance, PFG is willing to Forbear for the Extended Forbearance Period and provide the conditional limited waiver contained herein. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the foregoing Recitals,
incorporated by reference herein, and intending to be legally bound, the parties hereto agree as follows: 
 1. EVENT
OF DEFAULT. Borrower acknowledges the Default. 
 1 FORBEARANCE OF PFG.
Subject to Borrower’s performance of this Forbearance and the satisfaction of the conditions set forth in Section 8 hereof, PFG agrees to Forbear during the Extended Forbearance Period. In the event of a breach by Borrower of any of the
terms set forth in this Forbearance, a failure of any condition set forth in Section 9, or the occurrence of any Default under the Loan Documents other than a Permitted Default, PFG, at its option, with such notice to Borrower (if any) as may
be required by the Loan Documents, may terminate this Forbearance and exercise any remedies available to PFG under the Outstanding PFG Loans and under applicable law. For purposes of this Forbearance, a “Permitted Default”
shall mean the specific Default for which PFG is agreeing to Forbear hereunder as set forth under Recital D, above. 
 2 LIMITED
WAIVER. PFG hereby agrees to waive the Permitted Default for the Forbearance Period, subject to satisfaction of the conditions set forth in Section 9 hereof and Borrower’s compliance with the terms and
conditions of this Forbearance. 
 3 RESTRUCTURE OF CONVERTIBLE LOAN. Subject to
Borrower’s compliance with the terms of this Forbearance and provided that no Default or Event of Default has occurred and is continuing during the Extended Forbearance Period, PFG agrees to restructure of the Convertible Loan upon the terms
set forth below. Such restructuring shall be effected in an amendment to the agreement reflecting the Convertible Loan in such form as PFG may specify and Borrower may agree. 
 (a) If Borrower consummates an equity financing raising not less than $5,000,000 in net proceeds by the end of the Extended Forbearance Period, then PFG
will amend the Convertible Loan to include a minimum liquidity financial covenant to the effect that Borrower’s ratio of (i) cash and cash equivalents, plus eligible accounts receivable to (ii) outstanding monetary Obligations
to PFG, shall equal or exceed 2:1, tested on a calendar monthly basis. 
 (b) If Borrower is unable to consummate (or abandons the active
pursuit of) an equity financing raising not less than $5,000,000 in net proceeds by the end of the Extended Forbearance Period, then PFG will amend the Convertible Loan to apply a monthly borrowing base formula (in form substantially similar to the
borrowing base formula applicable to Borrower’s existing revolving credit facilities with PFG) to the Convertible Loan, such formula to equal 100% of Eligible Accounts plus 100% of Eligible Inventory. Any excess of outstanding monetary
Obligations under the Convertible Loan over formula-eligible borrowings (an “Overadvance”), would be required to be immediately repaid to PFG upon notice from PFG, at PFG’s sole option (and would not be eligible for re-borrowing by
Borrower). A liquidity covenant (as calculated in paragraph (a), above) would apply, but at a ratio of 1.25:1. The interest rate applicable to Obligations outstanding under the Convertible Loan would be at the prime rate, plus three percent (3%),
floating. For the avoidance of doubt, any reduction in principal amount of the Convertible Loan due to an Overadvance repayment required by PFG would reduce Convertible Loan eligible for PFG conversion into Borrower’s equity securities.

  

 2 

 5. BORROWER’ REPRESENTATIONS AND
WARRANTIES. Borrower represents and warrants that: 
 (a) immediately upon giving effect to this
Forbearance (i) the representations and warranties contained in the Loan Documents are true, accurate and complete (i.e., do not omit to state a material fact necessary in order to make the statements made, in light of the circumstances
which they were made, not misleading) in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they were true and correct as of such date), and (ii) no
Event of Default has occurred and is continuing, other than the Default(s) waived pursuant to this Forbearance; 
 (b) Borrower has
the corporate power and authority to execute and deliver this Forbearance and to perform its obligations under the Loan Documents, as amended by this Forbearance; 
 (c) the certificate of incorporation, bylaws and other organizational documents of Borrower delivered to PFG on the Effective Date remain true, accurate and complete and have not been amended, supplemented or
restated and are and continue to be in full force and effect; 
 (d) the execution, delivery and performance by Borrower of this
Forbearance have been duly authorized by all necessary corporate action on the part of Borrower; 
 (e) this Forbearance has been duly
executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against it in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or
other similar laws of general application and equitable principles relating to or affecting creditors’ rights; and 
 (f) as of
the date hereof, it has no known defenses against the obligations to pay any amounts under the Obligations and it has no known claims of any kind against PFG. Borrower acknowledges that, to its knowledge, PFG has acted in good faith and has
conducted in a commercially reasonable manner its relationships with Borrower in connection with this Forbearance and in connection with the Loan Documents. For purposes hereof, the term “knowledge” (and derivative terms) means the actual
knowledge of any executive officer of Borrower or such knowledge as a reasonably prudent executive officer of a U.S. publicly-traded corporation would have if such executive officer exercised reasonable diligence in the performance of his or her
legal duties and responsibilities. 
 Borrower understands and acknowledges that PFG is entering into this Forbearance in
reliance upon, and in partial consideration for, the above representations and warranties. 
 1 EFFECT ON
OUTSTANDING PFG LOANS. Except to the extent expressly set forth herein and as modified by the Original Forbearance, the terms of each of the Outstanding PFG Loans shall remain in effect and such
Outstanding PFG Loans shall be repaid as and when required in accordance with their respective terms. 
 2 RELEASE. Borrower hereby
forever relieves, releases, and discharges PFG and its present or former employees, officers, directors, agents, representatives, attorneys, and each of them, from any and all claims, debts, liabilities, demands, obligations, promises, acts,
agreements, costs and expenses, actions and causes of action, of every type, kind, nature, description or character, whether known or unknown, suspected or unsuspected, absolute or contingent, arising out of or in any manner connected with or
related to facts, circumstances, issues, controversies or claims existing or arising from the beginning of time through and including the date of execution of this Forbearance (collectively “Released Claims”). Without
limiting the foregoing, the Released Claims shall include any and all liabilities or claims (except for those arising from gross negligence or intentional misconduct in relation to any confidentiality obligations PFG may have in respect of Borrower)
arising out of or in any manner connected with or related to the Loan Documents, the Recitals hereto, any instruments, agreements or documents executed in connection with any of the foregoing or the origination, negotiation, administration,
servicing and/or 

  

 3 

 
enforcement of any of the foregoing. In furtherance of this release, Borrower expressly acknowledges and waives any and all rights under Section 1542 of
the California Civil Code, which provides as follows: “A general release does not extend to claims which the creditor does not know or expect to exist in his favor at the time of executing the release, which if known by him must have
materially affected his settlement with the debtor.” By entering into this release, Borrower recognizes that no facts or representations are ever absolutely certain and it may hereafter discover facts in addition to or different from those
which it presently knows or believes to be true, but that it is the intention of Borrower hereby to fully, finally and forever settle and release all matters, disputes and differences, known or unknown, suspected or unsuspected; accordingly, if any
Borrower should subsequently discover that any fact that it relied upon in entering into this release was untrue, or that any understanding of the facts was incorrect, neither Borrower shall be entitled to set aside this release by reason thereof,
regardless of any claim of mistake of fact or law or any other circumstances. Borrower acknowledges that it is not relying upon and has not relied upon any representation or statement made by PFG with respect to the facts underlying this release or
with regard to any of such party’s rights or asserted rights. This release may be pleaded as a full and complete defense and/or as a cross-complaint or counterclaim against any action, suit, or other proceeding that may be instituted,
prosecuted or attempted in breach of this release. Borrower acknowledges that the release contained herein constitutes a material inducement to PFG to enter into this Forbearance, and that PFG would not have done so but for PFG’s expectation
that such release is valid and enforceable in all events. Borrower hereby represents and warrants to PFG, and PFG is relying thereon, as follows: (i) except as expressly stated in this Forbearance, neither PFG nor any agent, employee or
representative of PFG has made any statement or representation to any Borrower regarding any fact relied upon by any Borrower in entering into this Forbearance; (ii) Borrower has made such investigation of the facts pertaining to this Forbearance
and all of the matters appertaining thereto, as it deems necessary; (iii) the terms of this Forbearance are contractual and not a mere recital; (iv) this Forbearance has been carefully read by Borrower, the contents hereof are known and
understood by Borrower, and this Forbearance is signed freely, and without duress, by Borrower; (v) Borrower represents and warrants that it is the sole and lawful owner of all right, title and interest in and to every claim and every other
matter which it releases herein, and that it has not heretofore assigned or transferred, or purported to assign or transfer, to any person, firm or entity any claims or other matters herein released. Borrower shall indemnify PFG, defend and hold it
harmless from and against all claims based upon or arising in connection with prior assignments or purported assignments or transfers of any claims or matters released herein. 
 1 LIMITATION. The forbearance, conditional limited waivers and amendments set forth in this Forbearance shall be limited precisely as written and shall not be deemed (a) to be
a forbearance, waiver or modification of any other term or condition of the Loan Agreement or of any other instrument or agreement referred to therein or to prejudice any right or remedy which PFG may now have or may have in the future under or in
connection with the Loan Agreement or any instrument or agreement referred to therein; (b) to be a consent to any future amendment or modification, forbearance or waiver to any instrument or agreement the execution and delivery of which is
consented to hereby, or to any waiver of any of the provisions thereof; or (c) to limit or impair PFG’s right to demand strict performance of all terms and covenants as of any date. Except as expressly amended hereby, the Loan Agreement
shall continue in full force and effect. 
 2 EFFECTIVENESS. Subject to the satisfaction of the conditions precedent set
forth below, this Forbearance shall become effective on the date hereof, but shall continue to be subject to the satisfaction of all the following conditions: 
 9.1 Execution and Delivery. Borrower and PFG shall have duly executed and delivered 

  

 4 

 
this Forbearance and all Amendments to PFG; 
 9.2 Payment of PFG Expenses. All PFG Expenses (including all reasonable attorneys’ fees and reasonable expenses) incurred in connection with this Forbearance shall immediately become a part of the
Borrower’s Obligations and shall be due and payable upon PFG demand. 
 9.3 Further Assurances. Borrower shall
execute and deliver such amendments, documents and instruments as are necessary or appropriate to effect the conditions to this Forbearance, including without limitation, the Amendments. 
 9.4 Forbearance Fee. Borrower shall have paid PFG a non-refundable Forbearance Fee equal to $15,000. 
 1 COUNTERPARTS. This Forbearance may be signed in any number of counterparts, and by different parties hereto in separate
counterparts, with the same effect as if the signatures to each such counterpart were upon a single instrument. All counterparts shall be deemed an original of this Forbearance. 
 2 INTEGRATION; CONSTRUCTION. This Forbearance, the Amendments and any other documents executed in connection herewith or therewith or pursuant hereto or thereto
contain the entire agreement between the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, offers and negotiations, oral or written, with respect thereto and no extrinsic evidence whatsoever may be
introduced in any judicial or arbitration proceeding, if any, involving this Forbearance; except that any financing statements or other agreements or instruments filed by PFG with respect to Borrower shall remain in full force and effect. The title
of this Agreement and section headings are for the readers’ convenience only and shall be ignored for purposes of integration into the Loan Agreement. The term “Schedule” means the Schedule to the Loan Agreement. 
 3 Severability. If one or more provisions of this Agreement are held to be unenforceable or are in violation of any applicable law or stock exchange rules or
regulations to which either Borrower of PFG is subject, the parties agree to renegotiate such provision in good faith, in order to maintain the economic position enjoyed by each party as close as possible to that under the provision rendered
unenforceable or that is in violation. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the
Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms. 
 1 GOVERNING LAW; VENUE. THIS FORBEARANCE SHALL BE GOVERNED BY AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA. Borrower and PFG each submit to
the exclusive jurisdiction of the State and Federal courts in San Francisco County, California. 
 2 TO THE EXTENT PERMITTED BY APPLICABLE LAW, PFG AND
BORROWER EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL
INDUCEMENT FOR BOTH PARTIES TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL. 
 WITHOUT
INTENDING IN ANY WAY TO LIMIT THE PARTIES’ AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a 

  

 5 

 
trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between them arising at any time shall be
decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the San Francisco County, California Superior Court) appointed in accordance with California Code of Civil Procedure
Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in San Francisco County, California; and the parties hereby submit to the
jurisdiction of such court. The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure §§ 638 through 645.1, inclusive. The private judge shall have the power, among
others, to grant provisional relief, including without limitation, entering temporary restraining orders and issuing preliminary and permanent injunctions. All such proceedings shall be closed to the public and confidential and all records relating
thereto shall be permanently sealed. If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference procedures, then such party may apply to the
San Francisco County, California Superior Court for such relief. The proceeding before the private judge shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial proceedings. The parties
shall be entitled to discovery which, other than a limitation of not more than 3 depositions per party of not more than 5 hours each, shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to
judicial proceedings. The private judge shall oversee discovery and may enforce all discovery rules and order applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or appointed private
judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to the California Code of Civil Procedure § 644(a). The private judge shall also
determine all issues relating to the applicability, interpretation, and enforceability of this paragraph and may grant appropriate relief from the terms of this paragraph for good cause shown. 
 IN WITNESS WHEREOF, the parties hereto have caused this Forbearance to be executed as of the date first written above. 
  

					
	BORROWER:	 	BIOJECT, INC.
		 	an Oregon corporation
			
	 	 	By:	 	/s/ Ralph Makar
		 	Printed Name: Ralph Makar
		 	Title:	 	President and CEO
		
	BORROWER:	 	BIOJECT MEDICAL TECHNOLOGIES, INC.
		 	an Oregon corporation
			
		 	By:	 	/s/ Ralph Makar
		 	Printed Name: Ralph Makar
		 	Title:	 	President and CEO
		
	PFG:	 	PARTNERS FOR GROWTH, L.P.
			
		 	By:	 	/s/ Andrew Kahn
		 	Printed Name: Andrew Kahn
		 	Title:	 	 Manager, Partners for Growth, LLC,
 its General
Partner

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]